News|Videos|December 2, 2024

GLP-1 RA antiobesity medications: Learning about side effects, and managing them

Key Takeaways

  • Side effects of GLP-1 RA drugs influence patient adherence, despite controlled research guiding physicians.
  • Real-world experiences may lead to treatment discontinuation due to physical side effects.
SHOW MORE

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Side effects play a role in a patient’s desire to use GLP-1 RA drugs for weight loss or other health conditions. Scientists studied the side effects in formal, controlled research that guides physicians when prescribing the drugs to patients. But real-world experiences may differ, and patients may not persist with a treatment regimen due to physical side effects. Cost and availability also play a role, said said Robert Kushner, MD. He has made a career as a researcher and author about overweight, obesity and nutrition. He’s also a doctor who has treated patients for years through Northwestern University’s Feinberg School of Medicine and Northwestern Medicine’s Center for Lifestyle Medicine.


Related to this article

Logan Ferrie: ©Genuine Health Group
Behavioral health has historically taken a back seat to physical health in primary care. That approach is shifting, as growing evidence underscores the importance of whole-person well-being in improving patient outcomes, strengthening care coordination and advancing value-based care.